Today we announced a historic and voluntary agreement with the U.S Government that will ensure U.S. patients pay lower prices for their prescription medicines while Pfizer continues to focus on delivering the next generation of breakthroughs.
Read the release DetailsThe companies announced they have entered into a definitive agreement under which Pfizer will acquire Metsera, a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and cardiometabolic diseases.
Read the release DetailsIn the fight against cancer, “one more” matters - one more wedding, one more hug, one more trial. Healthcare professionals won’t stop fighting for their patients, and neither will we.
Learn More at Let’sOutdoCancer.com DetailsPfizer RxPathways connects eligible patients to a range of assistance programs that offer insurance support, co-pay help, and medicines for free or at a savings.
Explore RxPathways DetailsAreas of Focus
Where people live shouldn’t impact the quality of their healthcare and income shouldn’t determine health outcomes.
Learn More About The Accord DetailsReceive the latest news from Pfizer in our monthly The Breakthrough newsletter and email alerts on a variety of topics.
Sign up now Details